Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Metformin, the most widely prescribed drug therapy for type 2 diabetes, has pleiotropic benefits, in addition to its capacity to lower elevated blood glucose levels, including mitigation of cardiovascular risk. The mechanisms underlying the latter remain unclear. Mechanistic studies have, hitherto, focused on the direct effects of metformin on the...
Alternative Titles
Full title
Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a8daeecc10fb48a6bbfa2297e4eae7e7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a8daeecc10fb48a6bbfa2297e4eae7e7
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph13110410
